LATEST UPDATES » Vol 26, Nos. 09 & 10, September & October 2022 – Toxins and Medicines – Two Sides of the Same Coin       » Utilising Metal Nanoparticles as Plant Growth Regulators to Improve Crop Yield       » Remedy or Poison? How Microplastics Influence Copper Ion Toxicity in Aquatic Plants       » Synthesising Schiff Base Antimicrobial Copper Complexes With Unprecedented Speed       » Enhancing the Understanding of Past Infections With Machine Learning       » Mini, Cellular Bioweapons: Understanding the Structure and Mechanism of Stinging in Sea Anemone Nematocysts       » Converting Dead Spiders Into Gripping Tools
WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December

Smithers E&L China is heading to Shanghai from 9-10 Dec 2020, bringing you a comprehensive, insightful and unrivalled programme covering the regulatory landscape, advances in science and testing methods, the latest technological developments, as well as featuring case studies from leading experts in E&L realm.

Since its launch in 2018, E&L has continued to grow and we expect a record year in 2020. The conference returns this year promising another unbeatable learning and networking experience for professionals such as yourself working within the E&L supply chain. Described as "premier gathering of expertise in E&L field", Smithers' E&L China 2020 conference will provide a 360-degree perspective of the E&L supply chain, with key insights from toxicologists, scientists, regulatory affairs managers, R&D managers and directors, E&L specialists, technical engineers and more.

Day one of the event will kick off with a session on Global regulatory landscape and updates on E&L, featuring keynote addresses from Andrew Teasdale, Senior Principal Scientist – Impurity Management and External Advocacy of AstraZeneca, and Queenie Gai, Global E&L Senior Consultant of Merck. The programme will then move on to look at Insights and perspectives from pharma and biotech companies, with a presentation from Xiaoxia Ye, Senior Analytical Researcher of Huadong Medicine, followed by a panel session surrounding challenges and the future trend of E&L studies and global requirements. Speakers from SCHOTT, Shanghai WEIPU and Intertek will discuss E&L in pharmaceutical packaging and drug delivery systems. Day one will be rounded off with a session on E&L in single use systems with speakers from Novo Nordisk, Saint-Gobain Life Sciences, Henlius, as well as Pall Corporation.

Another keynote speech will start off the proceedings on day two with Smithers opening the Challenges in E&L profiling: Identification session. Next session Safety assessments and toxicology will also feature speakers from U.S. FDA and Sartorius. The programme will then move on to look at E&L in medical devices, followed by several presentations from Shandong Quality Inspection Center for Medical Devices, Medtronic, WuXi AppTec, Baxter and Becton Dickinson. Speakers from Milestone and Shanghai Food and Drug Packaging Material Control Center will discuss From theory to practice: Experimental designs for E&L studies and case studies. The conference will then close with the final session looking at Focus on materials and biomaterials, featuring the speaker from West Pharmaceutical Packaging.

Presentations include:

  • Updates on ICH Q3E development and the challenges faced, Andrew Teasdale, Senior Principal Scientist – Impurity Management and External Advocacy, AstraZeneca
  • Challenges of E&L study on chemical drugs (parenteral) and drug delivery systems, Xiaojun Yang, Technical Director of Biomedical Technology Center, Shanghai WEIPU
  • Introduction on E&L study of single use system used in monoclonal antibody manufacturing process, Lei Zhang, Biology Analysis Development, Physicochemical Analysis Director, Henlius
  • Unknown E&L screening method establishment and its application in the biological evaluation, Dongdi Sun, Director of Chemistry Laboratory, Medical Device Testing Center, WuXi AppTec
  • Utilization of chemical characterization to support issues on standard compliance, Hongyu Luo, Principle Scientist, Baxter R&D, China
  • “Smithers E&L conference is the premier gathering of expertise in this field, I plan on attending every year” – DABT Chemistry & Materials Scientist, Nelson Labs
  • "An excellent opportunity to hear and discuss the approach of different organizations to the problem of E&L” – SGS M-Scan

Alongside the wealth of content focused on new innovations for pharmaceutical packaging, new developments in medical & drug device combination products and regulatory progress and test methods, E&L China 2020 will offer delegates the opportunity to network with thought-leaders and key players from across the supply chain in a number of dedicated networking breaks.

For more information on E&L China 2020 visit www.eandl-conference.com/extractables-leachables-china.

For further information please contact:
Beatrice Sun
[email protected]
+86 (0)512 6253 5582

What Has Covid Ever Done for Us?
news 2022 PDA Aseptic Processing of Biopharmaceuticals Conference
news Thailand LAB INTERNATIONAL, Bio Asia Pacific, and FutureCHEM INTERNATIONAL are ready to offer the Science and Technology Industry complete solutions this September!
news Better together: registration opens for Vitafoods Asia 2022 co-located with Fi Asia in October
news 2022 PDA Pharmaceutical Manufacturing & Quality Conference

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy